Roche Holding AG Stock Deutsche Boerse AG
Stocks
RHO5
CH0012032048
Pharmaceuticals
OTC Markets Traded| Market Cap | 297B 371B 318B 272B 512B 35,536B 522B 3,520B 1,372B 17,809B 1,394B 1,364B 58,961B | P/E 2026 * |
20.7x | P/E 2027 * | 18.4x |
|---|---|---|---|---|---|
| Enterprise Value | 308B 385B 330B 282B 530B 36,838B 541B 3,649B 1,422B 18,462B 1,446B 1,414B 61,120B | EV / Sales 2026 * |
4.91x | EV / Sales 2027 * | 4.59x |
| Free-Float |
88.78% | Yield 2026 * |
2.69% | Yield 2027 * | 2.75% |
Last Transcript: Roche Holding AG
| 1 day | -0.17% |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 51 | 2023-03-14 | |
Alan Hippe
DFI | Director of Finance/CFO | 59 | 2011-06-05 |
| Chief Operating Officer | - | 2025-09-30 |
| Director | Title | Age | Since |
|---|---|---|---|
André Hoffmann
BRD | Director/Board Member | 68 | 1995-12-31 |
Severin Schwan
CHM | Chairman | 59 | 2023-03-14 |
| Director/Board Member | 73 | 2015-03-02 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.17% | -4.91% | - | - | 371B | |
| -2.81% | +2.93% | +76.40% | +127.73% | 1,109B | |
| -2.21% | +2.02% | +49.50% | +55.01% | 644B | |
| -1.56% | +4.39% | +25.19% | +74.39% | 463B | |
| -1.43% | +2.62% | +41.69% | +45.78% | 371B | |
| -0.98% | +2.10% | +23.43% | +41.34% | 301B | |
| -0.88% | +3.25% | +0.94% | +13.42% | 256B | |
| -1.95% | +3.80% | +46.31% | +65.66% | 234B | |
| +0.55% | -0.70% | -14.31% | -52.66% | 205B | |
| -2.82% | +3.84% | +20.81% | +89.04% | 178B | |
| Average | -1.41% | +3.00% | +30.00% | +51.08% | 417.9B | |
| Weighted average by Cap. | -1.74% | +3.26% | +43.26% | +70.42% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 62.64B 78.42B 67.14B 57.48B 108B 7,503B 110B 743B 290B 3,760B 294B 288B 12,449B | 65.47B 81.96B 70.17B 60.08B 113B 7,842B 115B 777B 303B 3,930B 308B 301B 13,011B |
| Net income | 14.51B 18.16B 15.55B 13.31B 25.01B 1,738B 25.5B 172B 67.08B 871B 68.18B 66.7B 2,883B | 16.33B 20.45B 17.51B 14.99B 28.16B 1,956B 28.72B 194B 75.53B 980B 76.77B 75.1B 3,246B |
| Net Debt | 10.87B 13.6B 11.65B 9.97B 18.74B 1,302B 19.11B 129B 50.25B 652B 51.08B 49.96B 2,160B | 4.02B 5.03B 4.31B 3.69B 6.93B 481B 7.07B 47.69B 18.59B 241B 18.89B 18.48B 799B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
